| Particulars |
|
|
|
|
Company Name
| Cohance Lifesciences Ltd
|
Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
38.26 |
B.V. (₹) |
115.30 |
| Sales(₹ Cr.) |
1,093.51 |
NP (₹ Cr.) |
271.77 |
| NP Var% |
-8.00 |
Div% |
0.00 |
| CPS(₹) |
8.60 |
EPS (₹) |
7.10 |
| Traded Value(₹ Lakhs) |
6,566.79 |
52 Week High |
1,190.00 |
| 52 Week Low |
268.00 |
Price BSE |
433.00 |
| Price NSE |
432.00 |
Market Capital (₹ Cr.) |
16,553.68 |
| P/C Ratio |
50.40 |
P/E Ratio |
61.00 |
| Price Vs.BV |
3.76 |
|
| Latest Quarter |
| Year End |
202512 |
Sales (₹ Cr.) |
481.58 |
| NP(₹ Cr.) |
50.80 |
NP Var % |
-67.00 |
| Trailing Twelve Months |
| Year End |
202512 |
Sales |
914.50 |
| OPM |
38.71 |
NP |
247.20 |
| NP Var% |
-19.81 |
EPS |
8.84 |
| PE |
48.95 |
|
|